Stoneridge Investment Partners’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Stoneridge Investment Partners’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-121,050	Closed	-$369K	–	316
2014 Q4	$369K	Buy	121,050 +25,442	+27%	+$75.2K	0.05%	207
2014 Q3	$266K	Sell	95,608 -600	-0.6%	-$2.18K	0.04%	209
2014 Q2	$392K	Sell	96,208 -2,750	-3%	-$11.7K	0.06%	182
2014 Q1	$525K	Sell	98,958 -4,529	-4%	-$25.4K	0.1%	115
2013 Q4	$575K	Sell	103,487 -2,129	-2%	-$9.18K	0.11%	111
2013 Q3	$476K	Buy	105,616 +37,512	+55%	+$168K	0.1%	115
2013 Q2	$290K	Buy	+68,104	New	+$342K	0.07%	135

Other funds holding SGYP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stoneridge Investment Partners's SGYP Position: Q1 2015 in Review

Stoneridge Investment Partners sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2015, closing a stake of 121,050 shares — an estimated $369K sold.

Stoneridge Investment Partners first reported a position in SGYP in Q2 2013 and held it in 7 quarters. The position peaked at $575K in Q4 2013. 85 funds tracked by Wall St. Rank hold SGYP as of Q1 2015.

Stoneridge Investment Partners reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2015 after selling out during the quarter.
Stoneridge Investment Partners sold 121,050 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2015, an estimated $369K.
Stoneridge Investment Partners first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 7 quarters.
Stoneridge Investment Partners's Synergy Pharmaceuticals, Inc Common Stock position peaked at $575K in Q4 2013.
85 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2015.

Based on Stoneridge Investment Partners's 13F filing for Q1 2015, filed 23 Apr 2015.